| PERIOD ENDING | 29-Mar-09 | 31-Dec-08 | 28-Sep-08 | 29-Jun-08 | | Total Revenue | 5,884,000 | 6,086,000 | 5,864,000 | 5,870,000 | | Cost of Revenue | 4,697,000 | 4,910,000 | 4,674,000 | 4,670,000 | | | Gross Profit | 1,187,000 | 1,176,000 | 1,190,000 | 1,200,000 | | | Operating Expenses | | Research Development | 111,000 | 138,000 | 130,000 | 142,000 | | Selling General and Administrative | 364,000 | 392,000 | 380,000 | 396,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 712,000 | 646,000 | 680,000 | 662,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,000) | (4,000) | (2,000) | 19,000 | | Earnings Before Interest And Taxes | 711,000 | 642,000 | 678,000 | 681,000 | | Interest Expense | 32,000 | 32,000 | 29,000 | 34,000 | | Income Before Tax | 679,000 | 610,000 | 649,000 | 647,000 | | Income Tax Expense | 222,000 | 189,000 | 222,000 | 221,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 457,000 | 421,000 | 427,000 | 426,000 | | | Non-recurring Events | | Discontinued Operations | 3,000 |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 460,000 | 421,000 | 427,000 | 426,000 | | Preferred Stock And Other Adjustments | (8,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $452,000 | $421,000 | $427,000 | $426,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
